AGP Executive Report
Last update: 4 hours agoEU Referendum Watch: Iceland will hold a referendum on 29 August on whether to resume EU accession talks, with fisheries and sovereignty again at the center of the debate. Life Sciences Dealflow: Lupin’s VISUfarma has secured exclusive rights to commercialize Tenpoint’s presbyopia eye drop YUVEZZI across the EU, UK, Switzerland, Norway and Iceland, alongside a strategic investment and milestone/royalty structure. Biopharma Partnerships: IntraGel Therapeutics and UroGen Pharma ink an equity investment plus an option and research license tied to Tumocure, aiming to expand long-acting oncology pipelines. Energy & Industry: Reykjavík’s SnerpaPower lands €3.4m to help power-intensive firms turn electricity into a competitive advantage. Transport & Connectivity: Alaska Airlines plans new nonstop Seattle-to-Athens and Seattle-to-Paris routes in spring 2027, boosting Iceland’s wider North Atlantic travel and trade links. Mining & Greenland: Greenland Mines updates progress at Skaergaard and Sarfartoq and approves a 1-for-50 reverse stock split as it pushes field work forward. Infrastructure Planning: Eyjagöng signs with Norconsult for a cost and feasibility assessment of a subsea tunnel to the Westman Islands. Environment & Food Systems: Iceland’s ptarmigan hunting season could be extended by 11 days this year, while a study highlights how Iceland’s seafood cluster model helps turn byproducts into higher-value products.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
